New hope for patients with relapsed leukemia: experimental therapy STR-P004 enters early trial
NCT ID NCT07245251
First seen Nov 25, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-phase study tests a new drug called STR-P004 in 11 adults with a type of blood cancer (acute lymphoblastic leukemia) that has come back or not responded to standard treatments. The main goal is to check the drug's safety and find the right dose. Researchers will also look for signs that the drug is fighting the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBKASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.